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Abstract
Background: Evidence from population-based studies on the economic burden imposed by chronic
non-communicable diseases (CNCDs) is still sparse in Sub-Saharan Africa. Our study aimed to fill this
existing gap in knowledge by estimating both the household direct, indirect, and total costs incurred
due to CNCDs and the economic burden households bear as a result of these costs in Malawi.
Methods: The study used data from the first round of a longitudinal household health survey conducted
in 2012 in three rural districts in Malawi. A cost-of-illness method was applied to estimate the economic
burden of CNCDs. Indicators of catastrophic spending and impoverishment were used to estimate the
economic burden imposed by CNCDs on households.
Results: A total 475 out of 5643 interviewed individuals reported suffering from CNCDs. Mean total costs
of all reported CNCDs were 1,040.82 MWK, of which 56.8 % was contributed by direct costs. Individuals
affected by chronic cardiovascular conditions and chronic neuropsychiatric conditions bore the highest
levels of direct, indirect, and total costs. Using a threshold of 10 % of household non-food expenditure,
21.3 % of all households with at least one household member reporting a CNCD and seeking care for
such a condition incurred catastrophic spending due to CNCDs. The poorest households were more likely
to incur catastrophic spending due to CNCDs. An additional 1.7 % of households reporting a CNCD fell
under the international poverty line once considering direct costs due to CNCDs.
Conclusion: Our study showed that the economic burden of CNCDs is high, causes catastrophic spending,
and aggravates poverty in rural Malawi, a country where in principle basic care for CNCDs should be offered free of
charge at point of use through the provision of an Essential Health Package (EHP). Our findings further indicated that
particularly high direct, indirect, and total costs were linked to specific diagnoses, although costs were high even for
conditions targeted by the EHP. Our findings point at clear gaps in coverage in the current Malawian health system
and call for further investments to ensure adequate affordable care for people suffering from CNCDs.
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Background
Chronic non-communicable diseases (CNCDs), defined
as non-communicable conditions that affect people in
the long term [1], account for the vast majority of deaths
and are responsible for a notable economic burden in
low- and middle-income countries (LMICs). It has been
estimated that in 2010 alone, the economic loss due to
CNCDs amounted to 500 billion US Dollar (USD) in
LMICs, accounting for 4 % of these countries’ GDP [2].
The World Health Organization (WHO) predicts that
by 2030 the largest proportional rise in CNCD deaths
globally will occur in Sub-Saharan Africa (SSA), where the
disease burden of CNCDs is already very large [3].
Considering the paucity of adequate social protection
structures in most SSA countries [4], the increasing
economic burden due to CNCDs is likely to become ‘cata-
strophic’ and aggravate poverty among local communities,
who already struggle to meet basic daily needs [5].
Still, compared with communicable diseases, re-
searchers have paid limited attention to the economic
burden imposed by CNCDs in SSA [6]. The most rele-
vant evidence on the economic burden related to
CNCDs comes from high-income countries (HICs) [7].
In SSA, the few studies on costs associated with CNCDs
used facility-based convenience samples from patients
diagnosed with a specific CNCD [8–11] or relied on
various secondary data sources [12] or on projections
derived from assumptions of data and models first used
in other settings [13]. Evidence from population-based
studies specifically aimed at exploring the overall eco-
nomic burden imposed by CNCDs, especially by a broad
range of CNCDs, is still sparse in these settings. In
addition, to our knowledge, no study has been con-
ducted to assess the economic impact of CNCDs specif-
ically on affected households in SSA. The few existing
studies on catastrophic spending and impoverishment in
SSA used CNCDs as one of explanatory variables influ-
encing the odds of catastrophic spending and impover-
ishment [14, 15]. Evidence on the economic impact of
CNCDs specifically on affected households exists from
other settings in LMICs [16–18]. However, given
remarkable disparities in overall social and political
settings, the available evidence cannot provide direct
policy guidance for SSA governments.
This population-based study was designed to fill this
existing gap in knowledge by describing direct, indirect,
and total costs for the most frequently reported CNCDs
and the related economic impact of these conditions on
affected households in rural Malawi.
Methods
CNCDs and health service provision in Malawi
In recent years, CNCDs have been causing an increasing
number of deaths and disabilities in Malawi [19]. In
2008, CNCDs were estimated to account for 28 % of all
deaths [20], ranking second to HIV/AIDS as the most
prevalent cause of death in adults [21].
Health service provision in Malawi relies on a mixture
of public and private providers. Government funded
health provision consists of a combination of tax-based
and donor financing to ensure that services included in
the Essential Health Package (EHP) are provided free of
charge at point of use, at either public or contracted pri-
vate not-for-profit facilities. The EHP is meant as a
measure to advance progress towards universal coverage
and as such includes most priority health interventions
targeting the major causes of disease burden in the
country [22]. In 2010, the government expanded the
EHP to also include health interventions targeting the
most common CNCDs, such as screening, prevention,
and treatment of cardiovascular diseases, diabetes, and
certain cancers (breast cancer, cervical cancer) [21]. As
shown in our previous work, however, health service
utilization by people suffering from any of these CNCDs
remains rather poor [23].
Data and data collection
For this study, we used data from the first round of a
panel household survey conducted from August to
October 2012 in the districts of Thyolo, Chiradzulu, and
Mulanje in Southern Malawi. These districts count a
population of 1.4 million and include a total of 76 health
facilities offering the EHP (60 public facilities and 16
private not-for-profit facilities). In addition, there are 6
private for-profit facilities. Details of the sampling proce-
dures for the panel household survey have been
described elsewhere [23]. In brief, given that the ultimate
purpose of the panel was to evaluate the impact of a
micro-health insurance scheme to be launched by the
local Savings and Credit Cooperative (SACCO), the
panel included both households where at least one per-
son was a SACCO member (n = 691) and households
where no person was a SACCO member (n = 525). The
total sample included 5643 individuals distributed in
1199 households. The panel survey questionnaire col-
lected information on both household socio-
demographic and economic characteristics, on individual
illness profiles, and on the specific health seeking be-
havior (including costs) of people suffering from
acute and chronic conditions (the relevant sections
of the household survey questionnaire are included
in Additional file 1).
People suffering from at least one CNCD were identi-
fied in two steps. First, we asked respondents whether
they suffered from any chronic disease, which we
defined as any illness or complaint that persisted in an
individual longer than three months, or any recurrent
non-communicable illness episodes that had initially
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started in the past and continued to affect a respondent’s
health by the time of interview [24]. In a second step,
we collected information on diagnoses and/or symptoms
and recorded both clinical terminology and lay language
from all people reporting at least one chronic complaint
in order to further classify the reported chronic com-
plaints. Lists of diagnoses and symptoms were used to
facilitate data collection. Respondents were given the
option to record more than one chronic condition.
Using a simplified algorithm, each reported diagnosis or
symptom complex was assigned to one of ten WHO
categories for non-communicable conditions [3].
Once identified as suffering from a chronic condition,
individuals were asked a series of additional questions
pertaining to their health seeking behavior and related
direct and indirect costs. In consonance with other re-
searches [25–29], in order to minimize recall bias, we
used a four-week recall period to elicit responses on the
reported CNCD health seeking behavior and costs.
Variables and their measurements
We defined the primary outcome variables for this study
as the direct and indirect costs as well as the sum of
these two costs, i.e. total costs, incurred by an individual
due to CNCDs. All cost values are expressed in the local
currency, Malawian Kwacha (MWK) (1USD ~ 280MWK
at the time of survey). In addition, based on the analysis
of direct costs only, we looked at catastrophic spending
and impoverishment due to CNCDs.
Direct costs
We defined direct costs as the out-of-pocket expenditure
arising in the process of seeking care, including direct
medical and direct non-medical costs [30]. In this study,
direct medical costs included consultation fees, labora-
tory tests, drugs, medical aids, and disposables, while
direct non-medical costs included only transport costs
directly associated with all care-seeking events incurred
over the one-month recall period.
Indirect costs and total cost of illness
In line with prior research [31] using the human capital
approach (a most commonly used method of calculating
indirect cost in cost-of-illness studies, which estimates
the value of human life as the value of the output pro-
duced by the individual over his/her lifetime expressed
as a function of the individual’s earnings [32]), we esti-
mated indirect costs as the value of lost work time over
the set recall period due to CNCDs among the econom-
ically active persons (10–64 years) reporting such a con-
dition. Specifically, to estimate indirect costs and in line
with prior research [33] conducted in rural SSA, we
multiplied the country-specific minimum wage for 2012,
317 MWK per day [34], by the lost work time reported
by respondents as a consequence of CNCDs. Our ques-
tionnaire did not include questions to allow us to esti-
mate the opportunity costs incurred by caretakers of
people reporting a CNCD. Therefore, we could not in-
clude such an estimate in our calculations. Individuals
younger than 10 years or older than 64 years were
deemed to be economically non-active. Consistent with
a previous study conducted in Ethiopia [31], direct costs
were calculated only for those individuals who had
sought some form of care, while indirect costs were esti-
mated for all individuals aged 10 to 64 years, independ-
ently of whether they had sought care or not.
The total cost of illness due to CNCDs was estimated by
simply adding direct and indirect costs for all individuals
who reported at least one CNCD. When calculating total
costs, direct costs for those who did not seek any care and
indirect costs for those who were younger than 10 years
or older than 64 years were counted as zero [31].
Catastrophic spending
We defined catastrophic spending due to CNCDs as the
share of household out-of-pocket health expenditure
caused by CNCDs in relation to household non-
subsistence expenditure (total household expenditure
minus expenditure for basic subsistence needs) once ex-
ceeding a given threshold level [35]. In practice, in line
with previous studies [14, 35–37], we used food expend-
iture as a proxy of a household’s basic subsistence needs.
Also in line with prior research [36], we set the thresh-
old levels in this study were set at 10 %, 25 %, and 40 %.
Impoverishment
We defined impoverishment due to CNCDs as the
difference in poverty rate before paying for CNCD care
(i.e. pre-payment poverty rate) and after making such
payments (i.e. post-payment poverty rate), i.e. the per-
centage of non-poor households falling into poverty due
to direct costs associated with CNCDs [38, 39]. Due to
the fact that information on the national poverty line for
2012 was not available in Malawi, we used the inter-
national poverty line, $1.25 per person per day [40]. We
converted the $1.25 per person per day into the local
currency using the official 2012 purchasing power parity
exchange rate of 88.17 [41]. This yielded a poverty line
of 3306.4 MWK per person per month.
Analytical approach
Due to the uneven distribution of direct, indirect, and
total costs, we used mean, median, and inter-quartile
range to describe the central tendency of each of these
cost estimates. The incidence of catastrophic spending
due to CNCDs was computed as the proportion of
households incurring catastrophic spending in relation
to the total number of households reporting CNCDs
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[38, 42]. We also analyzed the distribution of the inci-
dence of catastrophic spending across social-economic
quartiles. The incidence of impoverishment due to
CNCDs was calculated in a similar way, i.e. the propor-
tion of households being impoverished in relation to the
total number of households reporting CNCDs [38, 42].
The four-week per capita household expenditure was used
as a proxy of social-economic status (SES) [24, 28, 43–45].
Per capita household expenditure was computed by divid-
ing total household expenditure by the number of people
living in a household. In this study, total household
expenditure included items on food, alcohol, clothing,
housing, transportation, communication, entertain-
ment, education, personal care, insurance, transfers
remittances, and health care (acute and chronic con-
ditions) spending.
Results
Out of 5643 individuals included in the survey, 475 (8.4 %)
reported a total of 515 chronic non-communicable condi-
tions (i.e. among these 475 individuals, on average, each
respondent reported 1.08 CNCDs). Out of the ten disease
categories used in our study to group chronic complaints,
the six most frequently reported were: chronic pains (n =
126, accounting for 24.5 % of all reported conditions),
chronic respiratory conditions (n = 98, 19.0 %), chronic
cardiovascular conditions (n = 95, 18.4 %), chronic sense
organ conditions (n = 65, 12.6 %), chronic neuropsychiatric
conditions (n = 47, 9.1 %), and chronic digestive conditions
(n = 42, 8.2 %). Chronic skin or oral conditions, malignant
neoplastic conditions, chronic genitourinary conditions,
and chronic endocrine conditions were excluded from fur-
ther analysis due to the small number of respondents in
these categories. Among the six most frequently reported
conditions, only chronic cardiovascular conditions
were covered by the EHP at the time of the study.
Out of these 475 respondents reporting at least one
CNCD, 298 (62.7 %), distributed in 244 households,
sought some form of either formal (services provided
by public facilities, private not-for-profit facilities, and
private for-profit facilities) or informal care (trad-
itional care and self-treatment) during the four weeks
preceding the interview, while 320 (67.4 %) were of
10 to 64 years of age.
Cost of illness
Among the 298 individuals who sought care for CNCDs,
mean monthly direct costs were 854.82MWK, with dir-
ect medical costs accounting for 75 % of direct costs.
Mean monthly direct costs were highest for individuals
seeking care for chronic neuropsychiatric and chronic
cardiovascular conditions, at 1,677.60 MWK (73.8 %
medical costs) and 1,617.83 MWK (60.6 % medical
costs) respectively. Mean monthly direct costs were low-
est for individuals with chronic sense organ conditions
and chronic digestive conditions, at 410.31 MWK
(82.5 % medical costs) and 416.38 MWK (80.5 %
medical costs), respectively (Table 1).
Among the 320 individuals aged 10 to 64 years report-
ing CNCDs, mean monthly indirect costs were 748.91
MWK with an average of 2.36 lost days per month due
to CNCDs. Among the six most frequently reported
CNCDs, those who reported chronic digestive condi-
tions, chronic neuropsychiatric conditions, and chronic
cardiovascular conditions bore the highest level of mean
monthly indirect costs (929.14 MWK, 898.17 MWK,
and 833.14 MWK respectively), while those who
reported chronic sense organ conditions and chronic
respiratory conditions bore the lowest mean monthly
indirect costs (503.47 MWK and 627.66 MWK, respect-
ively) (Table 2).
Mean monthly total costs, including both direct and
indirect costs, were 1,040.82 MWK, of which 56.8 % was
contributed by direct costs. Mean monthly total costs
were highest for individuals reporting chronic cardiovas-
cular conditions and chronic neuropsychiatric conditions
(1,723.99 MWK and 1,465.64 MWK respectively) and
lowest for individuals reporting chronic sense organ
conditions and chronic respiratory conditions (465.35
MWK and 623.60 MWK respectively) (Table 3).
Economic impact of CNCDs
Table 4 presents the incidence of catastrophic spending
due to CNCDs at the household level. Out of 244
Table 1 Direct cost of CNCDs of individuals who sought care in MWK
Mean Median Inter-quartile range Direct medical cost as %
of direct cost of illness
Total CNCD sample (n = 298) 854.82 150 (500, 0) 75.0 %
Chronic pain conditions (n = 89) 464.83 200 (400, 0) 79.0 %
Chronic respiratory conditions (n = 56) 530.89 50 (600, 0) 72.5 %
Chronic cardiovascular conditions (n = 60) 1617.83 150 (810, 0) 60.6 %
Chronic sense organ conditions (n = 32) 410.31 150 (500, 15) 82.5 %
Chronic neuropsychiatric conditions (n = 25) 1677.60 450 (1000, 100) 73.8 %
Chronic digestive conditions (n = 29) 416.38 150 (300, 0) 80.5 %
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households with at least one household member report-
ing a chronic non-communicable illness and seeking
care for such a condition, 21.3 % reported that direct
costs due to their chronic illness exceeded 10 % of
household non-food expenditure. Increasing the thresh-
old to 25 % and 40 % reduced the incidence of cata-
strophic spending to 10.7 % and 4.5 %, respectively. The
incidence of catastrophic spending was different across
SES quartiles with the poorest households being more
likely to incur catastrophic spending due to CNCDs.
Table 5 presents household impoverishment due to
CNCDs. Out of 244 households with at least one house-
hold member reporting a chronic non-communicable
condition and seeking care for such a condition, 43.0 %
already lived under the international poverty line of
$1.25 per person per day before expenses in form of any
direct out-of-pocket payment due to CNCDs occurred.
Once adjusted for spending on care for CNCDs, impov-
erishment increased to 44.7 % in respect to the inter-
national poverty line.
Discussion
To our knowledge, this is one of the very first studies
exploring the economic burden imposed on SSA house-
holds by a broad range of CNCDs, with information
derived from population-based rather than a facility-
based sample. Our findings indicate that CNCDs carry a
relatively high economic burden for the local population,
which causes financial stress and aggregates poverty in
rural Malawi. In addition, our study identified remark-
able differences in economic burden depending on the
specific condition affecting an individual. Considering
the scarcity of cost-of-illness studies on CNCDs in SSA,
we discuss our findings in relation to literature emerging
from other LMICs as well.
Our study found that direct costs accounted for the
largest portion of the total cost of illness across a broad
range of CNCDs, whereas direct medical costs com-
prised the largest portion of direct costs to the individual
as a result of these conditions. These findings are con-
sistent with cost-of-illness studies on cervical cancer [8]
and on heart failure [10] using facility-based data in SSA
and studies on hypertension [16] and on diabetes [46]
relying on population-based surveys from other LMICs.
These findings suggest that in Malawi, where care is in
principle free of charge at point of use, people still bear
an important burden due to direct costs caused by
CNCDs. In line with a prior qualitative study looking at
people’s perceptions of gaps in coverage [47], our find-
ings confirm that the officially free health system fails to
offer adequate financial protection against direct costs
due to CNCDs.
Also in line with prior evidence [8, 10, 16, 46], when
computing total cost of illness, indirect costs were found
to be of comparably high magnitude as direct costs. To
appreciate the magnitude of the indirect costs, one
needs to assess them against the value of the existing
poverty line. Moreover, one needs to consider that, given
Table 2 Indirect cost of individuals aged 10 to 64 years reporting at least one CNCD
Indirect cost (MWK) Lost days due to CNCD (days)
Mean Median Inter-quartile range Mean Median Inter-quartile range
Total CNCD sample (n = 320) 748.91 0 (951,0) 2.36 0 (3,0)
Chronic pain conditions (n = 95) 784.16 0 (951,0) 2.47 0 (3,0)
Chronic respiratory conditions (n = 50) 627.66 0 (951,0) 1.98 0 (3,0)
Chronic cardiovascular conditions (n = 78) 833.14 0 (1268,0) 2.63 0 (4,0)
Chronic sense organ conditions (n = 34) 503.47 0 (951,0) 1.59 0 (3,0)
Chronic neuropsychiatric conditions (n = 30) 898.17 0 (951,0) 2.83 0 (3,0)
Chronic digestive conditions (n = 29) 929.14 0 (1268,0) 2.93 0 (4,0)
Table 3 Total cost of CNCDs of all individuals reporting at least one CNCD in MWK
Mean Median Inter-quartile range Direct cost as % of total cost of illness
Total CNCD sample (n = 475) 1040.82 40 (1000, 0) 56.8 %
Chronic pain conditions (n = 126) 926.92 200 (1268, 0) 51.6 %
Chronic respiratory conditions (n = 98) 623.60 0 (900, 0) 60.8 %
Chronic cardiovascular conditions (n = 95) 1723.99 200 (1600, 0) 54.0 %
Chronic sense organ conditions (n = 65) 465.35 0 (357, 0) 66.4 %
Chronic neuropsychiatric conditions (n = 47) 1465.64 50 (951, 0) 65.2 %
Chronic digestive conditions (n = 42) 929.05 70 (1268, 0) 53.3 %
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our inability to value productivity losses by caregivers,
we might have underestimated the actual magnitude of
the productivity loss associated with CNCDs. In
addition, one needs to consider that productivity losses
in the SSA bear important consequences for households’
economic well-being, since social health protection
mechanisms are not sufficiently developed to provide
proper compensation for productivity losses due to
illness. Thus, productivity losses are born by ill people
themselves [48], since inability to work translates into
actual wealth losses. This represents an important gap in
social health protection, which adds to the burden
imposed by direct out-of-pocket spending and deserves
to be addressed equally urgently by local policy makers.
Among the most frequently reported CNCDs, we
showed that individuals affected by chronic cardiovascu-
lar conditions and chronic neuropsychiatric conditions
bore the highest levels of direct, indirect, and total costs.
This finding is in line with the report on the global eco-
nomic burden of non-communicable diseases recently
released by Harvard University [49]. Also, chronic
neuropsychiatric conditions, such as depression, anxiety,
or mental disorders, are currently not yet addressed by
the EHP in Malawi. In the light of our findings reporting
the importance of the economic burden associated with
these conditions, policy makers should consider expand-
ing coverage through the EHP since an expansion in
service coverage could translate into increased financial
protection for the local population.
The fact that chronic cardiovascular conditions re-
sulted in the highest level of direct costs appears even
more striking, given that these conditions are covered
by the EHP and related services should be provided
free of charge at point of use. Again in line with
prior qualitative evidence [47], our findings suggest
that policy does not translate into effective coverage
so that gaps in service coverage and financial protec-
tion remain very high, even for services explicitly
targeted by the EHP.
Our findings also revealed that a considerable propor-
tion of households incurred catastrophic spending due
to CNCDs. Poorest households faced the highest risk of
catastrophic spending due to CNCDs. These findings,
which rely on direct costs for CNCDs aggregated at the
household level, support findings from our previous
work, which pointed at the regressivity of individual out-
of-pocket expenditure on CNCDs [45]. These findings
are also consistent with prior analyses of catastrophic
spending, which included chronic conditions as an
explanatory variable in models targeting the overall eco-
nomic burden due to ill health in SSA [14, 15] and in
LMICs more in general [28, 39, 42, 50, 51]. These stud-
ies had already indicated how suffering from a chronic
condition represented an important determinant of cata-
strophic spending.
In addition, our study found that an additional 1.7 %
of households with at least one household member
reporting a CNCD fell under the international poverty
line once expenditures due to CNCDs were considered.
The fact that the economic burden of CNCDs aggravates
poverty is in line with previous studies focusing specific-
ally on the economic impact of CNCDs on affected
households [16, 18] and using CNCDs as explanatory
variable influencing the incidence of impoverishment
[15, 39, 42, 51] in LMICs. In the context of Malawi, this
finding appears worrisome in light of the rapid growth
of CNCDs and the fact that above 40 % of households
already live below the international poverty line.
Methodological considerations
At last, we need to consider a few limitations of our
study. First, as mentioned in the methods section, we
could not estimate caretakers’ productivity losses, due to
absence of relevant information from the survey. In
addition, our estimation of direct costs is likely to be
lower than their true value, since we did not have data
on other direct non-medical costs, such as food and ac-
commodation expenses incurred by the sick individuals
and their caretakers. Thus, both direct and indirect costs
resulting in the overall economic burden are likely to be
higher than what estimated in our study. Second, the in-
dividual’s earnings are not easily traceable in subsistence
societies where people produce most of what they will
consume [52]. This represents the main challenge in
applying the human capital approach to estimate indir-
ect costs in these settings. In line with previous research
[33], we used minimum wage as a proxy of the individ-
ual’s earnings in the informal sector. We need to be
aware that our study could have led to somewhat differ-
ent estimates of indirect cost if we had used different
proxies of one’s earnings (still based on the human cap-
ital approach) to estimate productivity losses, such as
the per capita Gross Domestic Product [53], per capita
Table 4 Incidence of household catastrophic spending due to
CNCDs
10 % 25 % 40 %
1st Quartile (lowest SES) (n = 51) 35.3 % 23.5 % 9.8 %
2nd Quartile (n = 44) 20.5 % 11.4 % 4.5 %
3rd Quartile (n = 65) 23.1 % 7.7 % 3.1 %
4th Quartile (highest SES) (n = 84) 11.9 % 4.8 % 2.4 %
Total (n = 244) 21.3 % 10.7 % 4.5 %
Table 5 Household impoverishment due to CNCDs (n = 244)
Pre-payment poverty rate Post-payment poverty rate
43.0 % 44.7 %
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expenditure [54], and the marginal product of labor
[55]. Furthermore, we need to consider that alterna-
tive methods of assessing productivity losses, not
based in the human capital approach, such as
willingness-to-pay could have potentially generated
higher estimates than ours [52, 56]. This can be ex-
plained in relation to the fact that willingness-to-pay
generates etimates based on a series of hypothetical
questions. As such, the method may induce respon-
dents to provider higher estimates than what they
would actually be willing to pay in reality [52]. Third,
both direct costs and productivity losses were esti-
mated based on information reported directly by the
individuals and may therefore be subject to recall
bias. Like in many other rural settings in SSA, it was
not possible for us to validate the veridicity of the
information provided by the respondents, given the
absence of formal medical booklets documenting
illness and healthcare seeking. The use of a four-week
recall period, rather than a longer recall period as
applied in other CNCD studies [24, 46, 57–59], was
designed to minimize recall bias [58, 60]. Still, in line
with prior research [61, 62], we cannot exclude that
in spite of our efforts to minimize recall bias, we did
not to some extent underestimate or overestimate dir-
ect and indirect costs. Underestimation of direct costs
might have occurred as the result of the fact that
individuals may incur direct expenditure related to
CNCD on larger time intervals and may have there-
fore not spent anything in the prior four weeks,
because still in possession of enough medications to
control their condition from a prior prescription. On
the contrary, overestimation of indirect costs might
have occurred as a result of potential over-reporting
time loss due to illness. Forth, since our study represents
an initial exploratory effort relying on population-based
data to estimate the economic burden imposed by CNCDs
in SSA, we did not have capacity to integrate measures of
intangible costs (e.g. the level of pain or suffering due to
specific health condition). Further studies are needed to
explore the intangible costs associated with suffering from
a CNCD in a SSA setting. Fifth, the methodology
currently available to estimate catastrophic spending and
impoverishment does not account for people who forego
care, since these individuals do not report any out-of-
pocket expenditure due to illness [38]. Households forgo-
ing treatment are usually the poorest in a community.
Forgoing treatment causes further deterioration of one’s
health, often leading to further economic losses and
deeper poverty. Thus, the real economic impact of
CNCDs is likely to be much higher than what can be esti-
mated using available methodology and what we were able
to show in our study, using catastrophic spending and
impoverishment as relevant indicators [36, 38].
Conclusion
Our study showed that in rural Malawi, the economic
burden of CNCDs remains high, leading households to
face catastrophic spending and pushing households fur-
ther into poverty. This finding is worrisome given that
in Malawi, health care services are set to be provided
free of charge at point of use for a broad range of condi-
tions, including several chronic non-communicable
ones. Our findings further indicated that particularly
high direct, indirect, and total costs were linked to spe-
cific diagnoses, but that in general costs were high even
for conditions in principle covered by the EHP. These
findings point at clear gaps in financial protection and
call for further investments, not only increasing effective
coverage of chronic conditions via the EHP, but also
expanding formal social health protection mechanisms,
such as offering monetary compensation for work lost in
case of illness. Further studies are needed to replicate
and thus validate our research findings in other SSA
settings.
Additional file
Additional file 1: The questionnaire for CNCDs. Data description:
the section for CNCDs in household survey questionnaire in our study
is presented in the file. (DOCX 31 kb)
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